A novel clinical entity: Triglyceride deposit cardiomyovasculopathy - Implications and perspectives from "obesity of the heart"

Journal of Atherosclerosis and Thrombosis

Volumn 16, Issue 5, 2009, Pages 702-705

  Hirano, Ken Ichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Adipose triglyceride lipase; Atherosclerosis; Cardiac transplantation; Congestive heart failure; Triglyceride deposit cardiomyovasculopathy; Triglycerides

Indexed keywords

TRIACYLGLYCEROL LIPASE;

ARTICLE; CHOLESTEROL BLOOD LEVEL; CONGESTIVE HEART FAILURE; GENE MUTATION; HEART DISEASE; HEART TRANSPLANTATION; HUMAN; HYDROLYSIS; LIPID STORAGE; LIPOGENESIS; MUSCLE CONTRACTILITY; OBESITY; OXIDATION; PHENOTYPE; TRIACYLGLYCEROL BLOOD LEVEL; TRIGLYCERIDE DEPOSIT CARDIOMYOVASCULOPATHY; VASCULAR DISEASE;

EID: 73249123539     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.1669     Document Type: Article

References (23)

1. Kannel WB, Dawber TR, Friedman GD, Glennon WE, McNamara PM: Risk factors in coronary heart disease. An evaluation of several serum lipids as predictors of coronary heart disease; The Framingham study. Ann Intern Med, 1964; 61: 888-899
2. Brown MS, Goldstein JL: Familial hypercholesterolemia: A genetic defect in the low density lipoprotein receptor. N Engl J Med, 1976; 294: 1386-1390
3. Endo A, Kuroda M, Tanzawa K: Competitive inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase by ML-236A and ML-236B fungal metabolites, having hypocholesterolemic activity. FEBS Lett, 1976; 72: 323-326
4. Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto Jr. AM, Kastelein JJP, Koenig W, Libby P, Lorenzatti AJ, MacFadyen JG, Nordestgaard BG, Shepherd J, Willerson JT, Glynn RJ for the JUPITER study group: Rosvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med, 2008; 359: 2195-2207
5. Ramasubbu K, Estep J, White DL, Deswal A, Mann DL: Experimental and clinical basis for the use of statins in patients with ischemic and nonischemic cardiomyopathy. J Am Coll Cardiol, 2008; 51: 415-426
6. Mazzone T, Chait A, Plutzky J: Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet, 2008; 371: 1800-1809
7. Asian Pacific Cohort Studies Collaboration: Serum triglycerides as a risk factor for cardiovascular disease in the Asia-Pacific Region. Circulation, 2004; 110: 2678-2686
8. Bottcher CJF, Boelsma-van Houte E, Ter Haar Romeny-Wachter CCh, Woodford FP, van Gent CM: Lipid and fatty-acid composition of coronary and cerebral arteries at different stages of atherosclerosis. Lancet, 1960; i: 1162-1167
9. Mendez J, Tejada C: Relation of severity of atherosclerosis to chemical composition of human aorta. Am J Clin Pathol, 1969; 51: 113-118
10. Zechner R, Kienesberger PC, Haemmerle G, Zimmermann R, Lass A: Adipose triglyceride lipase and the lipolytic catabolism of cellular fat stores. J Lipid Res, 2009; 50: 3-21
11. Bing RJ, Siegel A, Ungar I, Gilbert M: Metabolism of the human heart. II. Studies on fat, ketone, and amino acid metabolism. Am J Med, 1954; 16: 504-515
12. Hirano K, Ikeda Y, Zaima N, Sakata Y, Matsumiya G: Triglyceride deposit cardiomyovasculopathy. N Engl J Med, 2008; 359: 2396-2398
13. Haemmerle G, Lass A, Zimmermann R, Gorkiewicz G, Meyer C, Rozman J, Heldmaier G, Maier R, Theussl C, Eder S, Kratky D, Wagner EF, Klingenspor M, Hoefler G, Zechner R: Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science, 2006; 312: 734-737
14. Hasebe M: A case of Jordans' anomaly. Rinsho Ketsueki, 1983; 24: 553-558 (in Japanese)
15. Ibayashi H, Ideguchi M, Harada N, Ishimoto S, Goto I: Systemic triglyceride storage disease with normal carnitine: a putative defect in long chain fatty acid metabolism. J Neurol Sci, 1988; 85: 149-159
16. Oshima Y, Hirota H, Nagai H, Izumi M, Nakaoka Y, Osugi T, Fujio Y, Tateyama H, Kikui M, Yamauchi-Takihara K, Kawase I: Specific cardiomyopathy caused by multisystemic lipid storage in Jordan's anomaly. Circulation, 2002; 106: 280-281
17. Kobayashi K, Inoguchi T, Maeda Y, Nakashima N, Kuwano A, Eto E, Ueno N, Sasaki S, Sawada F, Fujii M, Matoba Y, Sumiyoshi S, Kawate H, Takayanagi R: The lack of the C-terminal domain of adipose triglyceride lipase causes neutral lipid storage disease through impaired interaction with lipid droplets. J Clin Endocrinol Metab, 2008; 93: 2877-2884
18. Akiyama M, Sakai K, Ogawa M, McMillan JR, Sawamura D, Shimizu H: Novel duplication mutation in the patatin domain of adipose triglyceride lipase (PNPLA2) in neutral lipid storage disease with severe myopathy. Muscle Nerve, 2007; 36: 856-859
19. Ross R: The pathogenesis of atherosclerosis - an update. N Engl J Med, 1986; 314: 488-500
20. Ross R: Atherosclerosis - an inflammatory disease. N Engl J Med, 1999; 340: 115-126
21. Goldstein JL, Brown MS: The clinical investigator: Bewitched, Bothered, and Bewildered - But still beloved. J Clin Invest, 1997; 99: 2803-2812
22. Fredrickson DS: The inheritance of high density lipoprotein deficiency (Tangier disease). J Clin Invest, 1964; 43: 228-236
23. Hansson GK: Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med, 2005; 352: 1685-1695